Impact of Achieving ASDAS LDA on Disease Activity and Patient-Reported Outcome Measures Among Patients with Ankylosing Spondylitis Treated with Biologic DMARDs - ACR Meeting Abstracts

Background/Purpose: Although Ankylosing Spondylitis Disease Activity Score (ASDAS) low disease activity (LDA) is a common treatment target for disease control when managing AS, real-world research describing ASDAS LDA achievement among patients treated with biologic DMARDs (bDMARD) is limited. The aim of this study was to describe disease activity and patient-reported outcome measures (PROMs) among patients […]

Oral Abstracts - 2020 - International Journal of Rheumatic

Relationship between disease activity status or clinical response

744, PDF, Rheumatoid Arthritis

Full article: POSTER PRESENTATIONS

Performance of 3 Composite Measures for Disease Activity in

PDF) Effectiveness and safety of adalimumab in patients with

Disease Activity-Guided Stepwise Tapering but Not Discontinuation

Efficacy of a tight-control and treat-to-target strategy in axial

PDF) Response to lower dose TNF inhibitors in axial

Upadacitinib efficacious in patients with ankylosing spondylitis

Full article: POSTER PRESENTATIONS

PDF) Effectiveness of switching between TNF inhibitors in patients

Full article: POSTER PRESENTATIONS